Skip to main content

Table 1 Patient characteristics

From: Impact of perioperative administration of 6 % hydroxyethyl starch 130/0.4 on serum cystatin C-derived renal function after radical prostatectomy: a single-centre retrospective study

Parameter, unit

Value

Age, yrs

64 (59 to 69)

Weight, kg

83.0 (76.0 to 90.0)

Height, m

1.8 (1.75 to 1.83)

ASA physical status classification

 I

12 (6.7)

 II

115 (64.2)

 III

43 (24.0)

 IV

1 (0.6)

 V

0 (0.0)

 VI

0 (0.0)

Medical co-morbidities

 Chronic arterial hypertension

80 (44.7)

 Chronic heart failure

1 (0.6)

 Coronary artery disease

7 (3.9)

 Cerebrovascular disease

11 (6.1)

 Periphery artery disease

1 (0.6)

 Atrial fibrillation

6 (3.4)

 Chronic kidney disease

1 (0.6)

 Diabetes mellitus

14 (7.8)

 Rheumatoid arthritis

2 (1.1)

Long-term Medication

 Diuretic (thiazide, indapamid)

17 (9.5)

 Diuretic (K+-sparing)

2 (1.2)

 Diuretic (loop of Henle)

0 (0.0)

 ACE-inhibitor

26 (14.5)

 AT1-blocker

41 (22.9)

 Renin-antagonist

1 (0.6)

 β-blocker

29 (16.2)

 Calcium channel-blocker

22 (12.3)

 α1-blocker

20 (11.2)

 α2-agonist

3 (1.7)

 NSAID

25 (13.9)

  1. Data presented as median (25th to 75th percentile) or number of cases (%)
  2. ASA American Society of Anesthesiologists, ACE angiotensin-converting-enzyme, AT1 angiotensin-receptor-1, NSAID non-steroidal anti-inflammatory drug